Steven A Tinge

Title: The Innovative Contributions of Steven A. Tinge

Introduction

Steven A. Tinge is a notable inventor based in Belleville, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative vaccine systems. With a total of 4 patents, Tinge's work focuses on enhancing the efficacy and safety of vaccines through advanced microbial technologies.

Latest Patents

One of Tinge's latest patents is the "Recombinant Bacterial Vaccine System with Environmentally Limited Viability." This patent discloses an Environmentally Limited Viability System (ELVS) for microorganisms, which utilizes temperature differences to control the viability of microorganisms in various environments. The system ensures that microorganisms express essential genes only in permissive environments, while lethal genes are expressed in non-permissive environments. This innovative approach is particularly beneficial for recombinant avirulent vaccines, as it limits the growth of the vaccine to the warmer environment inside the host. Such vaccines can protect humans and warm-blooded animals against a range of pathogens, including bacterial, viral, mycotic, and parasitic infections.

Another significant patent is the "Regulated Antigen Delivery System (RADS)." This system includes a vector with a gene encoding a desired product linked to a control sequence, allowing for precise regulation of gene expression. The RADS microorganisms are designed to provide high levels of the desired gene product after the repression of the high copy number origin of replication is lifted. This system is particularly useful for live bacterial vaccines, offering a delayed expression mechanism that enhances vaccine effectiveness.

Career Highlights

Throughout his career, Steven A. Tinge has worked with prestigious institutions, including Washington University and Avant Immunotherapeutics, Inc. His research has focused on developing innovative solutions to improve vaccine delivery and efficacy, making significant strides in the field of immunotherapy.

Collaborations

Tinge has collaborated with notable figures in the field, including Roy Curtiss III. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Steven A. Tinge's innovative work in the field of biotechnology, particularly in vaccine development, showcases his commitment to improving public health through scientific advancements. His patents reflect a deep understanding of microbial systems and their applications in medicine.